Mesenchymal Stem Cells for Treatment and Prevention of Graft-Versus- Host Disease After Allogeneic Hematopoietic Cell Transplantation
Journal:
Current Stem Cell Research & Therapy
Volume:
4
Page:
252-259
Author(s):
Tomomi Toubai, Sophie Paczesny, Yusuke Shono, Junji Tanaka, Kathleen P. Lowler, Chelsea T. Malter, Masaharu Kasai and Masahiro Imamura
Epigenetic Modifications: New Therapeutic Targets in Primary Myelofibrosis
Journal:
Current Stem Cell Research & Therapy
Volume:
4
Page:
281-286
Author(s):
Kirugaval Hemavathy and Jen C. Wang
Cancer Stem Cells in Pediatric Brain Tumors
Journal:
Current Stem Cell Research & Therapy
Volume:
4
Page:
298-305
Author(s):
Joseph L. Lasky III, Meeryo Choe and Ichiro Nakano
Structure, Function and Inhibition of Bcl-2 Family Proteins: A New Target for Anti-Tumor Agents
Journal:
Mini-Reviews in Medicinal Chemistry
Volume:
9
Page:
1596-1604
Author(s):
Guizhi Xiao, Hao Fang, Chengguo Xing and Wenfang Xu
Short- and Long-Term Survival of Nonsurgical Intensive Care Patients and its Relation to Diagnosis, Severity of Disease, Age and Comorbidities
Journal:
Current Aging Science
Volume:
2
Page:
240-248
Author(s):
Peter A. Kaufmann, Karl H. Smolle and Guenter J. Krejs
Molecular Imaging of Apoptosis In Vivo with Scintigraphic and Optical Biomarkers – A Status Report
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
9
Page:
968-985
Author(s):
Andreas Faust, Sven Hermann, Stefan Wagner, Gunther Haufe, Otmar Schober, Michael Schafers and Klaus Kopka
Regulation and Importance of the PI3K/Akt/mTOR Signaling Pathway in Hematologic Malignancies
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
9
Page:
1024-1038
Author(s):
Kiyotaka Kawauchi, Toshie Ogasawara, Masako Yasuyama, Kuniaki Otsuka and Osamu Yamada
Stem Cell and Gene Therapeutic Strategies for the Treatment of Multiple Sclerosis
Journal:
Current Molecular Medicine
Volume:
9
Page:
992-1016
Author(s):
Christopher Siatskas and Claude C. Bernard
The Combination of Conventional Chemotherapy with New Targeted Therapy in Hematologic Malignancies: The Safety and Efficiency of Low- Dose Cytarabine Supports its Combination with New Therapeutic Agents in Early Clinical Trials
Journal:
Current Cancer Therapy Reviews
Volume:
5
Page:
243-255
Author(s):
Hanne Fredly, Elisabeth Ersvaer, Camilla Stapnes, Bjorn Tore Gjertsen and Oystein Bruserud
Myeloid Malignancies and the Marrow Microenvironment: Some Recent Studies in Patients with MDS
Journal:
Current Cancer Therapy Reviews
Volume:
5
Page:
310-314
Author(s):
A. Mario Marcondes, Aravind Ramakrishnan and H. Joachim Deeg